NCT03856970View on ClinicalTrials.gov

Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

June 25, 2019

Study Completion Date

July 3, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Microgestin®

30 μg/1500 μg tablets for oral administration

DRUG

Levothyroxine

600 μg tablets for oral administration

DRUG

Glyburide

5 mg tablets for oral administration

DRUG

Digoxin

0.25 mg tablets for oral administration

DRUG

IW-3718

500-mg film-coated tablets for oral administration

Trial Locations (1)

78744

PPD, Austin

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY

NCT03856970 - Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter